Used as an intermediate in the synthesis of pharmaceutical agents, particularly in the development of beta-blockers and other cardiovascular drugs. Its chiral structure makes it valuable in enantioselective synthesis, where the (R)-enantiomer contributes to higher biological activity and selectivity. Commonly employed in the preparation of protease inhibitors and antihypertensive compounds due to its ability to enhance metabolic stability and binding affinity. Also utilized in research settings for asymmetric synthesis and development of novel chiral building blocks.